Effective cytotoxic treatment options for advanced cervical cancer are exceedingly limited.
Cisplatin-based combination chemotherapy, the most commonly used cytotoxic therapy, has …

Cervical cancer is the third most common cancer worldwide, and the development of new
diagnosis, prognostic, and treatment strategies is a major interest for public health. Cisplatin …

Cervical cancer represents the third most common cause of female cancer mortality. Even
with the best currently available treatment, a significant proportion of patients will experience …

Cervical cancer constitutes a leading cause of morbidity and cancer deaths in women
throughout the world. Approximately two thirds of the patients are diagnosed with locally …

Introduction: Worldwide, most cervical cancer (CC) patients require the use of drug therapy
either adjuvant, concurrent with radiation or palliative. Areas covered: This review briefly …

Introduction: There is a shortage of therapeutical agents for invasive cervical cancer in late
stages of development; however, a number of promising molecules are currently in early …

Introduction: Cervical cancer (CC) is currently the fourth most common malignant disease of
women worldwide. Although the incidence and the mortality rates have been decreasing …

According to international guidelines, treatment of cervical cancer (CC) consists of surgery in
early stages and of chemoradiation in locally advanced disease. Metastatic disease is …

Cervical cancer is the third most common malignant disease of women worldwide. Despite
advances in screening and treatment strategies, a significant number of patients have …

While widely employed in the management of cervical cancer, the overall utility of systemic
anti-neoplastic agents in this clinical setting is quite modest. Cisplatin, the single most …